WordNet

used especially of solids or solutions; incapable of blending into a stable homogeneous mixture
incapable of being used with or connected to other devices or components without modification
not compatible; "incompatible personalities"; "incompatible colors"
the 4th letter of the Roman alphabet (同)d
the 18th letter of the Roman alphabet (同)r
the state of being pregnant; the period from conception to birth when a woman carries a developing fetus in her uterus (同)gestation, maternity

PrepTutorEJDIC

両立しがたい,不調和な,矛盾した
deuteriumの化学記号
resistance / 17歳以下父兄同伴映画の表示 / rook
〈U〉〈C〉妊娠の状態(期間) / 〈U〉《文》含蓄
(おもに人称代名詞・固有名詞(人名),thereの後で)had, wouldの短縮形 / (疑問文でwhere,what,whenの後で)didの短縮形;Where'd he go?=Where did he go?

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 妊娠中のRh（D）同種免疫の概要 overview of rhesus rh alloimmunization in pregnancy
2. Rh（D）同種免疫を合併した妊娠のマネージメント management of pregnancy complicated by rhesus rh alloimmunization
3. Rh（D）同種免疫の予防 prevention of rh d alloimmunization
4. 妊娠中の予防接種 immunizations during pregnancy
5. 新生児の溶血性疾患：妊娠中のRBC同種抗体および関連する血清学的問題 hemolytic disease of the newborn rbc alloantibodies in pregnancy and associated serologic issues

Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study.

Cid J1, Lozano M, Ziman A, West KA, O'Brien KL, Murphy MF, Wendel S, Vázquez A, Ortín X, Hervig TA, Delaney M, Flegel WA, Yazer MH; Biomedical Excellence for Safer Transfusion collaborative.
British journal of haematology.Br J Haematol.2015 Feb;168(4):598-603. doi: 10.1111/bjh.13158. Epub 2014 Oct 4.
The reported frequency of D alloimmunization in D- recipients after transfusion of D+ platelets varies. This study was designed to determine the frequency of D alloimmunization, previously reported to be an average of 5 ± 2%. A primary anti-D immune response was defined as the detection of anti-D
PMID 25283094

Successful treatment of severe rhesus D-incompatible pregnancy with repeated double-filtration plasmapheresis.

Kamei K1, Yamaguchi K, Sato M, Ogura M, Ito S, Okada T, Wada S, Sago H.
Journal of clinical apheresis.J Clin Apher.2014 Nov 21. doi: 10.1002/jca.21372. [Epub ahead of print]
Fetal anemia is caused by Rhesus (RhD) sensitization as a result of RhD incompatibility during pregnancy. The severe form of this disease can cause hydrops fetalis leading to intrauterine death. We experienced a highly sensitized 39-year-old woman with B Rh-negative blood. She had a history of three
PMID 25413689

Late onset neonatal anaemia due to maternal anti-Kp(b) induced haemolytic disease of the newborn.

Elhence P1, Sachan D, Verma A, Kumar A, Chaudhary R.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.Transfus Apher Sci.2012 Dec;47(3):247-50. doi: 10.1016/j.transci.2012.09.001. Epub 2012 Oct 22.
BACKGROUND: Alloanti-Kp(b) is a rare, clinically significant antibody against high frequency red cell antigen Kp(b) of Kell blood group system. We report here a case of Haemolytic disease of newborn (HDN) due to anti-Kp(b), which manifested as severe anaemia at the age of 1 month.AIM: To diagnose an
PMID 23089052

花岡正智,久保隆彦
日本周産期・新生児医学会雑誌 = Journal of Japan Society of Perinatal and Neonatal Medicine 47(1), 60-63, 2011-05-01
NAID 10029381996

上田治子,大口昭英,渡辺尚,新井富士美,薄井里英,藤原寛行,高橋尚人,松原茂樹,鈴木光明
日本産婦人科・新生児血液学会誌 = The Japanese journal of obstetrical, gynecological & neonatal hematology 15(1), "S-65"-"S-66", 2005-06-01
NAID 10019221293

Brussow Klaus-Peter,Schneider Falk,Kanitz Ellen [他],OTTEN Winfried,TUCHSCHERER Margret
Journal of Reproduction and Development 51(1), 133-142, 2005
… Experiments were conducted in pregnant gilts (n=32) to characterize effects of elevated maternal glucocorticoids on the secretion of reproductive hormones (LH, progesterone) during the 1st (EXP 1), 2nd (EXP 2) and 3rd (EXP 3) trimester of pregnancy (TP). … Transiently elevated cortisol release was repeatedly achieved by application of 100 IU adenocorticotropic hormone (ACTH) (Synacthen Depot®) six times every second day beginning either on day 28 (EXP 1), day 49 (EXP 2) or day 75 of pregnancy (EXP 3). …
NAID 130000054762